Analyst consensus rating
Prestige Consumer Healthcare Analyst Rating: none
Direct answer
Prestige Consumer Healthcare's consensus rating is none.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $67.80.
Forecast evidence checked September 17, 2026.
Get free Prestige Consumer Healthcare email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $46.86
- Average price target
- $67.80
- High price target
- $75.00
- Low price target
- $55.00
- Low target gap
- +17.4%
- Target upside
- +44.7%
- High target gap
- +60.1%
- Target range width
- 42.7%
- Consensus rating
- none
- Analysts
- 5
- Evidence date
- September 17, 2026
- Valid through
- September 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Prestige Consumer Healthcare?
Prestige Consumer Healthcare has a verified none consensus. The same dataset has an average price target of $67.80.
How far are Prestige Consumer Healthcare's low and high targets from the recorded price?
The low target implies +17.4%, while the high target implies +60.1%.
How many analysts are included in Prestige Consumer Healthcare's consensus?
The verified consensus includes 5 analysts.
How is Prestige Consumer Healthcare's target upside or downside calculated?
The average target of $67.80 is divided by the recorded price of $46.86, then one is subtracted to produce +44.7%. This does not guarantee a future return.
When was Prestige Consumer Healthcare's analyst forecast verified?
The data was verified on 2026-09-17. The dataset is valid through 2026-09-24.